s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
3
Spiegel Robert J.: Initial statement of beneficial ownership of securities
Filed
Tuesday, September 22, 2026
Period
Sep 14, 2026
Accession number
0001493152-26-043714
Documents
3
3
On sec.gov
Filing index
All files
Complete submission text
SGML header